Navigation Links
Odyssey Thera Announces U.S. Patent for Technologies Enabling Protein Interaction Screening and Directed Evolution

SAN RAMON, Calif., Jan. 5, 2011 /PRNewswire/ -- Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167.  The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays (PCA).  The patent, the eighteenth assigned to Odyssey Thera, further protects assays utilizing fragments of inherently fluorescent proteins, and the use of these assays for high-throughput screening of defined panels of proteins.  The strategy is applicable in any cell type and using a wide range of reporters and detection methods.  The invention enables identification and validation of genes and proteins involved in any cellular process, and also provides assays to study the effects drugs and gene expression or knockout on specific pathways.

"This patent significantly extends the reach of Odyssey Thera's technology platform," said John K. Westwick, Ph.D., Odyssey Thera President and CEO.  "The assays and their use in gene vs. library and library vs. library screening provide a uniquely powerful strategy for biotherapeutic identification and optimization, diagnostic and biomarker development, the discovery of genetic modifiers of animal and plant cell traits, and bioprocess engineering."

About Odyssey Thera

Odyssey Thera, Inc. is a technology company committed to developing breakthroughs in cellular analysis and engineering.  Odyssey Thera's technologies measure pathway activity within living cells, and are applicable to therapeutic discovery and development, engineering of any cell type or species, live animal imaging, and diagnostic and bioprocess applications.  To learn more about Odyssey Thera, please visit

SOURCE Odyssey Thera, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Odyssey Thera to Participate in Expanded EPA Initiative
2. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
3. Stereotaxis and Siemens Promote Integrated Odyssey(TM) Solutions
4. Odyssey Thera Announces Achievement of Pfizer Drug Candidate Milestones
5. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
6. DJO Incorporated Acquires Manufacturer of Compression Therapy Products, Elastic Therapy, Inc.
7. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
8. Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
9. Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference
10. Graymark Healthcares Sleep Apnea Therapy Program Services Record Number of Patients in Q4 2010
11. Medco Extends URAC Accreditation to Drug Therapy Management, PBM
Post Your Comments:
(Date:12/1/2015)... 1, 2015 A federal court has denied the ... a lawsuit filed by the Pharmaceutical Care Management Association (PCMA) ... a new law that forces employers and consumers to pay ... Arkansas must now defend a law that raises ... and CEO Mark Merritt . --> ...
(Date:12/1/2015)... 2015 Pharma Tech Outlook recently conducted a ... Data Management Solution Providers - 2015 .  After careful ... CEOs, CIOs, VCs, analysts, and the Pharma Tech Outlook ... top 10 clinical data management solution providers (check out ... and 36 respectively). --> ...
(Date:12/1/2015)... Va. , Dec. 1, 2015  AccuTEC ... unveiled a new corporate logo and brand identity ... the design and engineering of bladed products where ... --> --> Serving manufacturers ... glass, and auto glass equipment, AccuTEC,s product lines ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... ... detailing the important role that meat and poultry play in a healthy, balanced ... a nutrition quiz where visitors can check their “meat IQ,” a section offering ...
(Date:12/1/2015)... Freeport, ME (PRWEB) , ... December 01, 2015 , ... ... — reports a new study that found post-menopausal women who took the nutritional supplement ... thigh than women who trained but did not take creatine. , The report is ...
(Date:12/1/2015)... ... December 01, 2015 , ... Physicians’ Education ... education (CME), today announced that the first annual School of Gastrointestinal Oncology™ (SOGO™) ... prevention, detection and treatment of gastrointestinal cancers are undergoing transformational change, providing oncologists ...
(Date:12/1/2015)... ... 01, 2015 , ... Speech and physical therapies are traditionally ... technologies and under the right circumstances, these practices can be merged. This ... to his or her therapeutic sessions, as well as gives the physical and ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... at the 7th Annual 2015 Golden Bridge Business Awards under the New Products ... a zero capex web based sample management software that helps labs ...
Breaking Medicine News(10 mins):